75F40122A00018-75F40126F19008
BPA Call
Overview
Government Description
BPA call order against 75F40122A00018 "drug labeling initiative BPA" to provide the oce continuity support
Awardee
Awarding / Funding Agency
Place of Performance
Silver Spring, MD 20993 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Not Competed Under Simplified Acquisition Procedures
Est. Average FTE
10
Related Opportunity
None
Deloitte Consulting was awarded
BPA Call 75F40126F19008 (75F401-26-F-19008)
for Bpa Call Order Against 75F40122A00018 "Drug Labeling Initiative Bpa" To Provide The Oce Continuity Support
worth up to $1,809,344
by the FDA Office of Acquisition and Grant Services
in December 2025.
The contract
has a duration of 1 year and
was awarded
full & open
with
NAICS 541990 and
PSC B528
via simplified acquisition acquisition procedures with 1 bid received.
Status
(Open)
Last Modified 12/3/25
Period of Performance
12/3/25
Start Date
11/29/26
Current End Date
11/29/26
Potential End Date
Obligations
$1.8M
Total Obligated
$1.8M
Current Award
$1.8M
Potential Award
Award Hierarchy
Activity Timeline
People
Suggested agency contacts for 75F40122A00018-75F40126F19008
Competition
Number of Bidders
1
Solicitation Procedures
Simplified Acquisition
Other Than Full and Open Competition
SAP Non-Competition
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
CKV2L9GZKJK3
Awardee CAGE
1TTG5
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhshilda_aryeh
Last Modified By
hhsian_weiss
Approved By
hhsian_weiss
Legislative
Legislative Mandates
None Applicable
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Modified: 12/3/25